Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > Second choice now I guess .Not the first ?, not the only ?
View:
Post by SamV21 on Oct 24, 2021 4:19pm

Second choice now I guess .Not the first ?, not the only ?

Right out of Tetras play book from September  2020

In the current context of cannabis legalization and significant shortages of nabilone, a drug used for chemotherapy-induced nausea and vomiting, our goal is to relaunch a high value therapeutic option with robust data. 

Under the terms of the agreement, TBP has agreed to acquire Dronabinol Soft Gel capsules commercial rights for two undisclosed milestones, 50% at the approval of the transaction and the other 50% once the DIN is granted by Health Canada.I guess that is why they can not give net numbers on income from it , undisclosed expences.

Dronabinol Soft Gel capsules are indicated in AIDS-related anorexia associated with weight loss and severe nausea and vomiting associated with cancer chemotherapy. Dronabinol DIN launch is expected in the first-half of 2021............We are now the the 4th Quarter of 2021 .
How are those milestones coming along ?

and you wonder why the price keeps going down, we have not seen the end of the drop in share price yet not by a long shot.
More fluff discussions , mean nothing , what is he going to say, you believe the garbage I'm sticking with results and the facts.Qixleef is light years away from being anything and Syqe has a product who Teva and Tilray are working on that is Health Canada approved already.

Comment by Realnewsalways1 on Oct 25, 2021 9:14am
Hey Clown, oh I mean Sam the Man.....Again puttting out misinformation hoping the not so informed will believe you... FACT-Simply go on Tetra website and see that they always indicated 2nd half of 2021 for sales to begin. FACT-Also they have provide guidance on sales for the product. FACT-Quixleef is half way through Ph 2 in Reborn trial.. Again, try and get out the basement of your moms house ...more  
Comment by NSX001 on Oct 25, 2021 9:39am
Good morning Realnewsalways1 Please just stop reponding to these clowns. When no one pays any notice they'll leave the board. Just put them on ignore. NSX001
Comment by Realnewsalways1 on Oct 25, 2021 9:44am
nsx001, you are right but he spreads blatant lies... I will put him on ignore but he wont go away because he is getting paid... see ya sam the man
Comment by SamV21 on Oct 25, 2021 10:30am
Right out of Tetras play book from September  2020 In the current context of cannabis legalization and significant shortages of nabilone, a drug used for chemotherapy-induced nausea and vomiting, our goal is to relaunch a high value therapeutic option with robust data.  Under the terms of the agreement, TBP has agreed to acquire Dronabinol Soft Gel capsules commercial rights for two ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities